BioCentury | Aug 29, 2019
Distillery Techniques

STAT3-based gene signature to predict response to glioblastoma targeted therapy

...Science Technology and Research, Singapore email: ang.beng.ti@singhealth.com.sg CONTACT: Carol Tang, Duke-NUS Graduate Medical School, Singapore; National Cancer Centre Singapore...
BioCentury | Apr 19, 2018
Emerging Company Profile

Engine power

...by Jeffrey Lu, Timothy Lu, Prashant Mali, Hu Li University collaborators: Massachusetts Institute of Technology, National Cancer Centre Singapore...
BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...long non-coding RNA (lncRNA) EGFR-AS1 could help treat head and neck squamous cell carcinoma (HNSCC). National Cancer Centre Singapore...
BioCentury | Oct 31, 2017
Distillery Therapeutics

Cancer

...Tan, National Cancer Centre Singapore, Singapore email: daniel.tan.s.w@singhealth.com.sg CONTACT: N. Gopalakrishna Iyer, same affiliation as above email: gopaliyer@nccs.com.sg Hongjiang Li National Cancer Centre Singapore EGFR...
BioCentury | Dec 2, 2016
Company News

Parker Institute, CRI form neoantigen initiative

...Jolla Institute for Allergy & Immunology Ludwig Institute for Cancer Research Ltd. MedImmune LLC Memorial Sloan Kettering Cancer Center National Cancer Centre Singapore Neon...
BioCentury | Sep 10, 2015
Emerging Company Profile

Epitope as prologue

...before out-licensing the antibodies for further development. The company is working with partners including the National Cancer Centre Singapore...
...Inc. (NASDAQ:AVEO), Cambridge, Mass. Hummingbird Bioscience Pte. Ltd., Singapore Merrimack Pharmaceuticals Inc. (NASDAQ:MACK), Cambridge, Mass. National Cancer Centre Singapore...
BioCentury | Jul 17, 2015
Company News

Aslan, NCCS to study GI cancers

...Aslan Pharmaceuticals Pte. Ltd. (Singapore) and the National Cancer Centre Singapore signed a memorandum of understanding to jointly study...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: Tumor protein 73 (p73; TP73)

Cancer INDICATION: Cancer Studies in cell culture, mice and patient samples suggest inhibiting TP73 could help treat cancer. In human colon cancer and lung adenocarcinoma cell lines, hypoxic conditions up-regulated TP73 expression. In a mouse...
BioCentury | Jan 27, 2014
Company News

Clearbridge BioMedics, National Cancer Centre Singapore (NCCS), Singapore General Hospital diagnostic, pharmacogenetics news

...said the partners will jointly commercialize resulting products from CTC CoRE. Clearbridge BioMedics , Singapore National Cancer Centre Singapore...
BioCentury | Dec 17, 2012
Company News

Sirtex Medical, National Cancer Centre Singapore, Singapore General Hospital deal

...Australian National University. The partners did not disclose details. Sirtex Medical Ltd. (ASX:SRX), Sydney, Australia National Cancer Centre Singapore...
Items per page:
1 - 10 of 13
BioCentury | Aug 29, 2019
Distillery Techniques

STAT3-based gene signature to predict response to glioblastoma targeted therapy

...Science Technology and Research, Singapore email: ang.beng.ti@singhealth.com.sg CONTACT: Carol Tang, Duke-NUS Graduate Medical School, Singapore; National Cancer Centre Singapore...
BioCentury | Apr 19, 2018
Emerging Company Profile

Engine power

...by Jeffrey Lu, Timothy Lu, Prashant Mali, Hu Li University collaborators: Massachusetts Institute of Technology, National Cancer Centre Singapore...
BioCentury | Nov 1, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2017

...long non-coding RNA (lncRNA) EGFR-AS1 could help treat head and neck squamous cell carcinoma (HNSCC). National Cancer Centre Singapore...
BioCentury | Oct 31, 2017
Distillery Therapeutics

Cancer

...Tan, National Cancer Centre Singapore, Singapore email: daniel.tan.s.w@singhealth.com.sg CONTACT: N. Gopalakrishna Iyer, same affiliation as above email: gopaliyer@nccs.com.sg Hongjiang Li National Cancer Centre Singapore EGFR...
BioCentury | Dec 2, 2016
Company News

Parker Institute, CRI form neoantigen initiative

...Jolla Institute for Allergy & Immunology Ludwig Institute for Cancer Research Ltd. MedImmune LLC Memorial Sloan Kettering Cancer Center National Cancer Centre Singapore Neon...
BioCentury | Sep 10, 2015
Emerging Company Profile

Epitope as prologue

...before out-licensing the antibodies for further development. The company is working with partners including the National Cancer Centre Singapore...
...Inc. (NASDAQ:AVEO), Cambridge, Mass. Hummingbird Bioscience Pte. Ltd., Singapore Merrimack Pharmaceuticals Inc. (NASDAQ:MACK), Cambridge, Mass. National Cancer Centre Singapore...
BioCentury | Jul 17, 2015
Company News

Aslan, NCCS to study GI cancers

...Aslan Pharmaceuticals Pte. Ltd. (Singapore) and the National Cancer Centre Singapore signed a memorandum of understanding to jointly study...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: Tumor protein 73 (p73; TP73)

Cancer INDICATION: Cancer Studies in cell culture, mice and patient samples suggest inhibiting TP73 could help treat cancer. In human colon cancer and lung adenocarcinoma cell lines, hypoxic conditions up-regulated TP73 expression. In a mouse...
BioCentury | Jan 27, 2014
Company News

Clearbridge BioMedics, National Cancer Centre Singapore (NCCS), Singapore General Hospital diagnostic, pharmacogenetics news

...said the partners will jointly commercialize resulting products from CTC CoRE. Clearbridge BioMedics , Singapore National Cancer Centre Singapore...
BioCentury | Dec 17, 2012
Company News

Sirtex Medical, National Cancer Centre Singapore, Singapore General Hospital deal

...Australian National University. The partners did not disclose details. Sirtex Medical Ltd. (ASX:SRX), Sydney, Australia National Cancer Centre Singapore...
Items per page:
1 - 10 of 13